Hydroxychloroquine-associated QT interval prolongation

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1803卷 / 1期
关键词：
D O I：
10.1007/s40278-020-78204-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 10
相关论文
共 50 条
  • [31] PROLONGATION OF THE QT INTERVAL BY KETANSERIN
    CAMERON, HA
    WALLER, PC
    RAMSAY, LE
    POSTGRADUATE MEDICAL JOURNAL, 1988, 64 (748) : 112 - 117
  • [32] EXPERIMENTAL QT INTERVAL PROLONGATION
    MALFATTO, G
    STEINBERG, SF
    ROSEN, TS
    DANILO, P
    ROSEN, MR
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1992, 644 : 74 - 83
  • [33] Rivastigmine and QT interval prolongation
    Inglis, F
    BRITISH JOURNAL OF PSYCHIATRY, 2003, 182 : 549 - 550
  • [34] QT interval prolongation and beyond
    Couderc, Jean-Philippe
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2006, 11 (04) : 287 - 288
  • [35] SYNCOPE AND QT INTERVAL PROLONGATION
    MEZGER, J
    ETTINGER, U
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1990, 132 (46): : 730 - 731
  • [36] Hydroxychloroquine: risk of QT prolongation and drug interactions
    Reactions Weekly, 2020, 1819 (1) : 1 - 1
  • [37] Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation
    Bonow, Robert O.
    Hernandez, Adrian F.
    Turakhia, Mintu
    JAMA CARDIOLOGY, 2020, 5 (09) : 986 - 987
  • [38] Comparison of hydroxychloroquine plus moxifloxacin versus hydroxychloroquine alone on corrected QT interval prolongation in COVID-19 patients
    Yavuz, Veysel
    Ozyurtlu, Ferhat
    Cetin, Nurullah
    COR ET VASA, 2021, 63 (05) : 564 - 571
  • [39] QT interval prolongation associated with low magnesium in chronic alcoholics
    Alvarenga Moulin, Stephanie Rezende
    Mill, Jose Geraldo
    Monico Rosa, Werther Clay
    Hermisdorf, Silas Rubens
    Caldeira, Lunielle da Cruz
    Zago-Gomes, Maria da Penha
    DRUG AND ALCOHOL DEPENDENCE, 2015, 155 : 195 - 201
  • [40] Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics
    Jimmi Nielsen
    Claus Graff
    Jørgen K. Kanters
    Egon Toft
    David Taylor
    Jonathan M. Meyer
    CNS Drugs, 2011, 25 : 473 - 490
12345